series-b
Stage
2017
Founded
3
Investors
About
Nautilus Biotechnology develops a single-molecule proteomics platform and laboratory instruments to sequence and quantify proteins at large scale, enabling high-throughput protein analysis for research and diagnostic applications.
Explore Nautilus Biotechnology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.